Duexis

Zollinger-Ellison Syndrome, Curling Ulcer, Indigestion + 21 more
Treatment
2 FDA approvals
20 Active Studies for Duexis

What is Duexis

FamotidineThe Generic name of this drug
Treatment SummaryFamotidine is a medication used to reduce the production of stomach acid. It works by blocking the histamine-2 receptor, which helps to inhibit acid secretion in the stomach. It is commonly used to treat conditions such as gastric ulcers and GERD in both adults and children. It is more potent than similar medications, such as cimetidine and ranitidine, and can be taken as a pill or intravenously in a hospital setting.
Pepcidis the brand name
image of different drug pills on a surface
Duexis Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Pepcid
Famotidine
1986
623

Approved as Treatment by the FDA

Famotidine, also called Pepcid, is approved by the FDA for 2 uses which include Heartburn and Heartburn .
Heartburn
Heartburn

Effectiveness

How Duexis Affects PatientsFamotidine works by reducing acid in the stomach and decreasing the amount of acid and digestive enzymes produced. It's effects can be felt within one hour and last up to 12 hours. The more you take, the longer it will last and the more it will reduce your stomach acid.
How Duexis works in the bodyHistamine is a hormone that tells stomach cells to produce acid. This happens when enterochromaffin-like cells release histamine, which is also triggered by the hormone gastrin. Histamine binds to receptors on the stomach cells, which increases the production of acid. In cases of ulcers or other conditions where too much acid is produced, famotidine steps in. Famotidine blocks the action of histamine on the stomach cells, reducing the amount of acid they produce.

When to interrupt dosage

The proposed measure of Duexis is contingent upon the diagnosed circumstance, such as Heartburn, Heartburn and Pathological Conditions, Anatomical. The measure of dosage is contingent upon the mode of administration (e.g. Tablet, film coated - Oral or Oral) exemplified in the table beneath.
Condition
Dosage
Administration
Erosive Esophagitis
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Heartburn
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Gastric ulcer
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Helicobacter Pylori Infection
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Zollinger-Ellison Syndrome
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Pain
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Heartburn
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Critical Illness
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Muscle Spasms
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Osteoarthritis (OA)
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Chronic Back Pain
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
prophylaxis of Stress Ulcers
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Stress Ulcers
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Duodenal Ulcer
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
gastrointestinal ulceration
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Collagen Diseases
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Heartburn
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
weight 40 kg or more
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Curling Ulcer
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous
Indigestion
, 10.0 mg/mL, 10.0 mg, 40.0 mg, 2.0 mg/mL, 20.0 mg, 40.0 mg/mL, 26.6 mg
, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, Tablet - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral, Injection, Injection - Intravenous, Tablet, coated, Tablet, coated - Oral, For suspension, For suspension - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Solution - Intravenous, Solution, Powder, for solution, Powder, for solution - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous

Warnings

Duexis has one contraindication, so it ought not to be taken in combination with the conditions indicated in the following table.Duexis Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Duexis.
Common Duexis Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The excretion of Abemaciclib can be decreased when combined with Famotidine.
Acenocoumarol
Major
The metabolism of Acenocoumarol can be decreased when combined with Famotidine.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Famotidine.
Anagrelide
Major
The metabolism of Anagrelide can be decreased when combined with Famotidine.
Atazanavir
Major
Famotidine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Duexis Toxicity & Overdose RiskThe lowest dose of famotidine that has been found to be toxic in rats is 4049mg/kg, and 4686mg/kg in mice. The lowest toxic dose in humans is 4mg/kg, taken over a 7 day period. Symptoms of famotidine overdose are similar to those of recommended doses, and can be treated with supportive and symptomatic care. Removing unabsorbed drug from the gastrointestinal system and monitoring the patient is necessary. Hemodialysis can also be used to remove the drug from the bloodstream.
image of a doctor in a lab doing drug, clinical research

Duexis Novel Uses: Which Conditions Have a Clinical Trial Featuring Duexis?

45 active clinical trials are examining the potential of Duexis to ameliorate Collagen Diseases, Acid Indigestion and Muscle Spasms.
Condition
Clinical Trials
Trial Phases
Zollinger-Ellison Syndrome
0 Actively Recruiting
Multiple Endocrine Neoplasia
1 Actively Recruiting
Phase 2
Stress Ulcers
0 Actively Recruiting
Heartburn
2 Actively Recruiting
Phase 3, Not Applicable
Indigestion
13 Actively Recruiting
Phase 3, Not Applicable, Early Phase 1, Phase 2, Phase 1, Phase 4
Curling Ulcer
0 Actively Recruiting
Gastritis
4 Actively Recruiting
Phase 2, Not Applicable, Phase 3
Postoperative Pain
21 Actively Recruiting
Phase 4, Phase 1, Not Applicable, Phase 3, Early Phase 1, Phase 2
Critical Illness
0 Actively Recruiting
Duodenal Ulcer
0 Actively Recruiting
Gastric ulcer
0 Actively Recruiting
Heartburn
0 Actively Recruiting
Chronic Back Pain
2 Actively Recruiting
Not Applicable
Collagen Diseases
0 Actively Recruiting
Muscle Spasms
0 Actively Recruiting
Erosive Esophagitis
3 Actively Recruiting
Phase 2, Phase 3
weight 40 kg or more
0 Actively Recruiting
Pathological Conditions, Anatomical
0 Actively Recruiting
Osteoarthritis (OA)
0 Actively Recruiting
prophylaxis of Stress Ulcers
0 Actively Recruiting

Duexis Reviews: What are patients saying about Duexis?

5Patient Review
8/6/2016
Duexis for Osteoarthritis and High Risk of Developing Gastric Ulcers
This treatment is really effective. I take it along with norco 10 and it does a great job at relieving my pain.
5Patient Review
2/1/2019
Duexis for Joint Damage causing Pain and Loss of Function
The manufacturer's discount on this drug was incredible--60 pills for only $10. However, they withdrew the discount and now each pill costs $2,000. I've had to switch to taking ibuprofen and Pepcid ac daily, which is a real bummer. If you're on Medicare, beware that you won't be able to receive the discount either.
5Patient Review
11/6/2016
Duexis for Osteoarthritis and High Risk of Developing Gastric Ulcers
I started taking this medication because I was having stomach problems with other pills. However, this pill helped my lower back pain.
5Patient Review
12/22/2016
Duexis for Joint Damage causing Pain and Loss of Function
This drug has been a huge help for my plantar fasciitis.
5Patient Review
3/27/2016
Duexis for Joint Damage causing Pain and Loss of Function
5Patient Review
5/19/2017
Duexis for Rheumatoid Arthritis
Out of all the pills I've taken for my osteoarthritis, Duexis is the only one that's actually helped me. Not to mention, their co-pay card has been a lifesaver.
3.7Patient Review
3/20/2019
Duexis for Gout
Kicks in 15-30 min and allows me to take it as needed. It manages any pain flare ups after a busy weekend doing yard work or house work. It works great and does not affect my GERD. My insurance did not want to pay for it so it came from a mail away pharmacy for $10. Cannot beat it. Great stuff.
3Patient Review
7/15/2018
Duexis for Joint Damage causing Pain and Loss of Function
This medication is great for managing pain. I've used it for migraines, back pain, knee pain, and wrist pain with success. It usually kicks in within half an hour, which is awesome. Plus, it doesn't make me drowsy which is a huge plus.
2.7Patient Review
7/29/2016
Duexis for Joint Damage causing Pain and Loss of Function
2.3Patient Review
6/15/2017
Duexis for Joint Damage causing Pain and Loss of Function
Durexis helps with the pain from my surgery, but it only lasts for a few hours. I'm glad it exists, but I wish it were more effective.
1Patient Review
5/21/2016
Duexis for Joint Damage causing Pain and Loss of Function
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about duexis

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug DUEXIS used for?

"DUEXIS can be used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis, as well as decrease the risk of developing ulcers of the stomach and upper intestines in people taking ibuprofen for these conditions."

Answered by AI

Is DUEXIS good for inflammation?

"DUEXIS can provide OA and RA symptom relief, including pain and inflammation, when you would prefer to take a medication over having surgery. DUEXIS also has a lower risk of giving you stomach ulcers then ibuprofen taken alone."

Answered by AI

Is DUEXIS stronger than ibuprofen?

"DUEXIS® was also superior to ibuprofen in decreasing the risk for both gastric and duodenal ulcers."

Answered by AI

What is the difference between DUEXIS and ibuprofen?

"Are Duexis and Ibuprofen the Same Thing?

Duexis is a combination of ibuprofen and famotidine, and is used to treat signs and symptoms of rheumatoid arthritis. Because it contains famotidine, Duexis is also effective in reducing the risk of developing upper gastrointestinal ulcers. Ibuprofen is also used to treat primary dysmenorrhea."

Answered by AI

Clinical Trials for Duexis

Have you considered Duexis clinical trials? We made a collection of clinical trials featuring Duexis, we think they might fit your search criteria.
Have you considered Duexis clinical trials? We made a collection of clinical trials featuring Duexis, we think they might fit your search criteria.
Have you considered Duexis clinical trials? We made a collection of clinical trials featuring Duexis, we think they might fit your search criteria.